Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
311 JPY | -6.04% | -7.44% | -49.68% |
Business Summary
Number of employees: 24
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 72 | 100.0 % | 94 | 100.0 % | +30.96% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
54.2
%
| 37 | 51.2 % | 51 | 54.2 % | +38.57% |
Japan
45.8
%
| 35 | 48.8 % | 43 | 45.8 % | +22.96% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Takuya Yokogawa
PSD | President | 63 | 01/18/01 |
Tadashi Matsuura
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/05/01 |
Yasuo Ichinose
ADM | Chief Administrative Officer | - | - |
Chief Administrative Officer | 68 | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Takao Hamakubo
BRD | Director/Board Member | - | - |
Nobuo Hanai
BRD | Director/Board Member | 71 | 01/21/01 |
Chief Administrative Officer | 68 | 01/19/01 | |
Takuya Yokogawa
PSD | President | 63 | 01/18/01 |
Director/Board Member | 57 | 01/18/01 | |
Takashi Ono
BRD | Director/Board Member | 54 | 01/21/01 |
Yasuo Ichinose
ADM | Chief Administrative Officer | - | - |
Nobuo Hanai
BRD | Director/Board Member | - | - |
Tatsuya Nagakiyo
BRD | Director/Board Member | 67 | 23/22/23 |
Tadashi Horiuchi
BRD | Director/Board Member | 77 | 01/19/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 12,325,100 | 11,002,543 ( 89.27 %) | 47 ( 0.000381 %) | 89.27 % |
Company contact information
Sector
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-49.68% | 2.63Cr | |
+0.10% | 9.14TCr | |
+2.76% | 4.11TCr | |
-11.80% | 3.43TCr | |
+53.68% | 2.53TCr | |
-9.35% | 1.28TCr | |
-12.11% | 1.16TCr | |
-43.61% | 1.14TCr | |
+5.24% | 915.59Cr | |
-6.90% | 821.79Cr |
- Stock Market
- Equities
- 4882 Stock
- Company Perseus Proteomics Inc.